228 related articles for article (PubMed ID: 32380584)
1. The Value of Tumor Treating Fields in Glioblastoma.
Zhang C; Du J; Xu W; Huang H; Gao L
J Korean Neurosurg Soc; 2020 Nov; 63(6):681-688. PubMed ID: 32380584
[TBL] [Abstract][Full Text] [Related]
2. Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment.
DesJarlais AM; Miller R; Ali AS; Niazi MZ; Cappelli L; Glass J; Farrell CJ; Shi W
Chin Clin Oncol; 2023 Dec; 12(6):69. PubMed ID: 38195076
[TBL] [Abstract][Full Text] [Related]
3. Tumor treating fields: a new standard treatment for glioblastoma?
Taillibert S; Le Rhun E; Chamberlain MC
Curr Opin Neurol; 2015 Dec; 28(6):659-64. PubMed ID: 26551239
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
Saria MG; Kesari S
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
[TBL] [Abstract][Full Text] [Related]
5. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
[TBL] [Abstract][Full Text] [Related]
6. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.
Jones AB; Schanel TL; Rigsby MR; Griguer CE; McFarland BC; Anderson JC; Willey CD; Hjelmeland AB
Cells; 2023 Aug; 12(17):. PubMed ID: 37681903
[TBL] [Abstract][Full Text] [Related]
7. Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series.
Ansstas G; Tran DD
Case Rep Neurol; 2016; 8(1):1-9. PubMed ID: 26889149
[TBL] [Abstract][Full Text] [Related]
8. Tumor treating fields: a novel and effective therapy for glioblastoma: mechanism, efficacy, safety and future perspectives.
Zhu P; Zhu JJ
Chin Clin Oncol; 2017 Aug; 6(4):41. PubMed ID: 28841803
[TBL] [Abstract][Full Text] [Related]
9. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
Kesari S; Ram Z;
CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
[TBL] [Abstract][Full Text] [Related]
10. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
11. Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
Ballo MT; Conlon P; Lavy-Shahaf G; Kinzel A; Vymazal J; Rulseh AM
J Neurooncol; 2023 Aug; 164(1):1-9. PubMed ID: 37493865
[TBL] [Abstract][Full Text] [Related]
12. Case report: tumor-treating fields prolongs IDH-mutant anaplastic astrocytoma progression-free survival and pathological evolution to glioblastoma.
Lin Y; Chen B
Ann Transl Med; 2021 Dec; 9(24):1804. PubMed ID: 35071498
[TBL] [Abstract][Full Text] [Related]
13. Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields.
Kessler AF; Linsenmann T; Westermaier T; Wolber W; Weiland J; Monoranu CM; Breun M; Hagemann C; Ernestus RI; Löhr M
Oncol Lett; 2020 Jan; 19(1):557-561. PubMed ID: 31897171
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Treating Fields in Glioblastomas: Past, Present, and Future.
Guo X; Yang X; Wu J; Yang H; Li Y; Li J; Liu Q; Wu C; Xing H; Liu P; Wang Y; Hu C; Ma W
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954334
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.
Fabian D; Guillermo Prieto Eibl MDP; Alnahhas I; Sebastian N; Giglio P; Puduvalli V; Gonzalez J; Palmer JD
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717372
[TBL] [Abstract][Full Text] [Related]
16. Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study.
Guzauskas GF; Pollom EL; Stieber VW; Wang BCM; Garrison LP
J Med Econ; 2019 Oct; 22(10):1006-1013. PubMed ID: 31050315
[No Abstract] [Full Text] [Related]
17. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
Riley MM; San P; Lok E; Swanson KD; Wong ET
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901
[TBL] [Abstract][Full Text] [Related]
18. Tumour treating fields in a combinational therapeutic approach.
Branter J; Basu S; Smith S
Oncotarget; 2018 Nov; 9(93):36631-36644. PubMed ID: 30564303
[TBL] [Abstract][Full Text] [Related]
19. Tumor treating fields: a comprehensive overview of the underlying molecular mechanism.
Hong P; Kudulaiti N; Wu S; Nie J; Zhuang D
Expert Rev Mol Diagn; 2022 Jan; 22(1):19-28. PubMed ID: 34883030
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Treating Fields Therapy for Pediatric Brain Tumors.
Makimoto A; Nishikawa R; Terashima K; Kurihara J; Fujisaki H; Ihara S; Morikawa Y; Yuza Y
Neurol Int; 2021 Apr; 13(2):151-165. PubMed ID: 33917660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]